|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III, Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
70 and under
|
|
|
|
NCI
|
|
|
|
EST-PE-179
|
|
|
|
|
|
|
|
Last Modified: 12/17/2007  First Published: 12/1/1993 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
pre-/perimenopausal
|
|
|
|
|
|
|
|
CAN-NCIC-MA12 NCI-V93-0323, NCT00002542, MA12
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
35 to 80
|
|
|
|
|
|
|
|
GER-AIO-02/92 EU-93010
|
|
|
|
|
|
|
|
Last Modified: 5/8/2007  First Published: 9/1/1994 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
pre/postmenopausal
|
|
|
|
|
|
|
|
SCTN-BR9403 EU-94004, NCT00002579
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
Not specified
|
|
|
|
|
|
|
|
NCRI-ABC CRC-TU-BR3010, SCTN-BR9401/BR9402, YRCO-ABC, EU-94029, UKCCCR-ABC, NCT00002582
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
over 16
|
|
|
|
|
|
|
|
IBCSG-IX EU-94040
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
pre/perimenopausal 30 and over
|
|
|
|
|
|
|
|
CNR-GROCTA-010209 EU-93018
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
20 to 65
|
|
|
|
Other
|
|
|
|
YALE-HIC-7996 NCI-V95-0728
|
|
|
|
|
|
|
|
Last Modified: 12/28/2006 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Temporarily closed
|
|
|
|
21 to 75
|
|
|
|
Other
|
|
|
|
GOCS-08-BR-95-III NCI-F95-0036, NCT00002696
|
|
|
|
|
|
|
|
Last Modified: 5/8/2007  First Published: 6/1/1996 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
over 18
|
|
|
|
|
|
|
|
SCTN-BR9405 EU-95048, NCT00002755
|
|
|
|